Rosette-forming and papillary glioneuronal tumors - A clinicopathological and molecular analysis

Rosette-forming glioneuronal tumors (RGNT) and papillary glioneuronal tumors (PGNT) account for < 1% of brain tumors. Genetic data regarding RGNT and PGNT is still evolving. We aimed to perform a detailed clinicopathological analysis on rosette-forming and papillary glioneuronal tumors and to eva...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical neuropathology 2019-07, Vol.38 (4), p.180-188
Hauptverfasser: Singh, Vikram, Gupta, Kirti, Salunke, Pravin, Kumar, Sandeep, Radotra, Bishan Dass, Vasishta, Rakesh Kumar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 188
container_issue 4
container_start_page 180
container_title Clinical neuropathology
container_volume 38
creator Singh, Vikram
Gupta, Kirti
Salunke, Pravin
Kumar, Sandeep
Radotra, Bishan Dass
Vasishta, Rakesh Kumar
description Rosette-forming glioneuronal tumors (RGNT) and papillary glioneuronal tumors (PGNT) account for < 1% of brain tumors. Genetic data regarding RGNT and PGNT is still evolving. We aimed to perform a detailed clinicopathological analysis on rosette-forming and papillary glioneuronal tumors and to evaluate these for common, known genetic mutations. Our cohort consisted of 6 cases of these rare glioneuronal tumors diagnosed over a period of 5 years. IDH1, ATRX, p53, and BRAF V600E mutations were evaluated on immunohistochemistry, and cases of RGNT were screened for the mutations in gene at hotspots exon 4, 9, and 20. Our findings confirm the presence of gene mutations in RGNT along with two novel mutations in gene, of which one is proposed to be of prognostic significance.
.
doi_str_mv 10.5414/NP301164
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2196514474</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2196514474</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-b5877c24ef226fba766bb4d72ea2a835e868e3ee40f6982903dc2db9ce8803603</originalsourceid><addsrcrecordid>eNpdkE1LxDAQhnNQ3PUD_AVS8OKlmq8m6XFZ_IJFRfRc03S6ZkmbmrQH_71ZdBU8DcM88847L0KnBF8WnPCrhyeGCRF8D82xpDQvcElm6DDGDcYFlUIcoBnDJcalknP09uwjjCPkrQ-d7deZ7pts0IN1TofPbO2s72EKvtcuG6fOh5jl2SIzzvbW-EGP7975tTVpvN3svAMzpdXUafcZbTxG-612EU5-6hF6vbl-Wd7lq8fb--VilRtGyJjXhZLSUA4tpaKtdfJZ17yRFDTVihWghAIGwHErSkVLzBpDm7o0oBRmArMjdPGtOwT_MUEcq85GA-mNHvwUK0pKURDOJU_o-T9046eQ_CaKSVwwkg78CZrgYwzQVkOwXQqlIrjaJl3tkk7o2Y_gVHfQ_IK7mNkXU7B6pg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2370531829</pqid></control><display><type>article</type><title>Rosette-forming and papillary glioneuronal tumors - A clinicopathological and molecular analysis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Singh, Vikram ; Gupta, Kirti ; Salunke, Pravin ; Kumar, Sandeep ; Radotra, Bishan Dass ; Vasishta, Rakesh Kumar</creator><creatorcontrib>Singh, Vikram ; Gupta, Kirti ; Salunke, Pravin ; Kumar, Sandeep ; Radotra, Bishan Dass ; Vasishta, Rakesh Kumar</creatorcontrib><description>Rosette-forming glioneuronal tumors (RGNT) and papillary glioneuronal tumors (PGNT) account for &lt; 1% of brain tumors. Genetic data regarding RGNT and PGNT is still evolving. We aimed to perform a detailed clinicopathological analysis on rosette-forming and papillary glioneuronal tumors and to evaluate these for common, known genetic mutations. Our cohort consisted of 6 cases of these rare glioneuronal tumors diagnosed over a period of 5 years. IDH1, ATRX, p53, and BRAF V600E mutations were evaluated on immunohistochemistry, and cases of RGNT were screened for the mutations in gene at hotspots exon 4, 9, and 20. Our findings confirm the presence of gene mutations in RGNT along with two novel mutations in gene, of which one is proposed to be of prognostic significance.
.</description><identifier>ISSN: 0722-5091</identifier><identifier>DOI: 10.5414/NP301164</identifier><identifier>PMID: 30900987</identifier><language>eng</language><publisher>Germany: Dustri - Verlag Dr. Karl Feistle GmbH &amp; Co. KG</publisher><subject>Adult ; Age ; Brain cancer ; Brain Neoplasms - diagnosis ; Brain Neoplasms - pathology ; Central Nervous System Neoplasms - diagnosis ; Central Nervous System Neoplasms - pathology ; Cerebral Ventricle Neoplasms - diagnosis ; Cerebral Ventricle Neoplasms - pathology ; Female ; Histopathology ; Humans ; Immunohistochemistry - methods ; Male ; Medical education ; Morphology ; Mutation ; Mutation - genetics ; Neoplasms, Neuroepithelial - diagnosis ; Neoplasms, Neuroepithelial - pathology ; Pathology, Molecular - methods ; Prognosis ; Rosette Formation - methods ; Tumors ; Young Adult</subject><ispartof>Clinical neuropathology, 2019-07, Vol.38 (4), p.180-188</ispartof><rights>Copyright Dustri - Verlag Dr. Karl Feistle GmbH &amp; Co. KG Jul/Aug 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-b5877c24ef226fba766bb4d72ea2a835e868e3ee40f6982903dc2db9ce8803603</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30900987$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Singh, Vikram</creatorcontrib><creatorcontrib>Gupta, Kirti</creatorcontrib><creatorcontrib>Salunke, Pravin</creatorcontrib><creatorcontrib>Kumar, Sandeep</creatorcontrib><creatorcontrib>Radotra, Bishan Dass</creatorcontrib><creatorcontrib>Vasishta, Rakesh Kumar</creatorcontrib><title>Rosette-forming and papillary glioneuronal tumors - A clinicopathological and molecular analysis</title><title>Clinical neuropathology</title><addtitle>Clin Neuropathol</addtitle><description>Rosette-forming glioneuronal tumors (RGNT) and papillary glioneuronal tumors (PGNT) account for &lt; 1% of brain tumors. Genetic data regarding RGNT and PGNT is still evolving. We aimed to perform a detailed clinicopathological analysis on rosette-forming and papillary glioneuronal tumors and to evaluate these for common, known genetic mutations. Our cohort consisted of 6 cases of these rare glioneuronal tumors diagnosed over a period of 5 years. IDH1, ATRX, p53, and BRAF V600E mutations were evaluated on immunohistochemistry, and cases of RGNT were screened for the mutations in gene at hotspots exon 4, 9, and 20. Our findings confirm the presence of gene mutations in RGNT along with two novel mutations in gene, of which one is proposed to be of prognostic significance.
.</description><subject>Adult</subject><subject>Age</subject><subject>Brain cancer</subject><subject>Brain Neoplasms - diagnosis</subject><subject>Brain Neoplasms - pathology</subject><subject>Central Nervous System Neoplasms - diagnosis</subject><subject>Central Nervous System Neoplasms - pathology</subject><subject>Cerebral Ventricle Neoplasms - diagnosis</subject><subject>Cerebral Ventricle Neoplasms - pathology</subject><subject>Female</subject><subject>Histopathology</subject><subject>Humans</subject><subject>Immunohistochemistry - methods</subject><subject>Male</subject><subject>Medical education</subject><subject>Morphology</subject><subject>Mutation</subject><subject>Mutation - genetics</subject><subject>Neoplasms, Neuroepithelial - diagnosis</subject><subject>Neoplasms, Neuroepithelial - pathology</subject><subject>Pathology, Molecular - methods</subject><subject>Prognosis</subject><subject>Rosette Formation - methods</subject><subject>Tumors</subject><subject>Young Adult</subject><issn>0722-5091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkE1LxDAQhnNQ3PUD_AVS8OKlmq8m6XFZ_IJFRfRc03S6ZkmbmrQH_71ZdBU8DcM88847L0KnBF8WnPCrhyeGCRF8D82xpDQvcElm6DDGDcYFlUIcoBnDJcalknP09uwjjCPkrQ-d7deZ7pts0IN1TofPbO2s72EKvtcuG6fOh5jl2SIzzvbW-EGP7975tTVpvN3svAMzpdXUafcZbTxG-612EU5-6hF6vbl-Wd7lq8fb--VilRtGyJjXhZLSUA4tpaKtdfJZ17yRFDTVihWghAIGwHErSkVLzBpDm7o0oBRmArMjdPGtOwT_MUEcq85GA-mNHvwUK0pKURDOJU_o-T9046eQ_CaKSVwwkg78CZrgYwzQVkOwXQqlIrjaJl3tkk7o2Y_gVHfQ_IK7mNkXU7B6pg</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Singh, Vikram</creator><creator>Gupta, Kirti</creator><creator>Salunke, Pravin</creator><creator>Kumar, Sandeep</creator><creator>Radotra, Bishan Dass</creator><creator>Vasishta, Rakesh Kumar</creator><general>Dustri - Verlag Dr. Karl Feistle GmbH &amp; Co. KG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>201907</creationdate><title>Rosette-forming and papillary glioneuronal tumors - A clinicopathological and molecular analysis</title><author>Singh, Vikram ; Gupta, Kirti ; Salunke, Pravin ; Kumar, Sandeep ; Radotra, Bishan Dass ; Vasishta, Rakesh Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-b5877c24ef226fba766bb4d72ea2a835e868e3ee40f6982903dc2db9ce8803603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Age</topic><topic>Brain cancer</topic><topic>Brain Neoplasms - diagnosis</topic><topic>Brain Neoplasms - pathology</topic><topic>Central Nervous System Neoplasms - diagnosis</topic><topic>Central Nervous System Neoplasms - pathology</topic><topic>Cerebral Ventricle Neoplasms - diagnosis</topic><topic>Cerebral Ventricle Neoplasms - pathology</topic><topic>Female</topic><topic>Histopathology</topic><topic>Humans</topic><topic>Immunohistochemistry - methods</topic><topic>Male</topic><topic>Medical education</topic><topic>Morphology</topic><topic>Mutation</topic><topic>Mutation - genetics</topic><topic>Neoplasms, Neuroepithelial - diagnosis</topic><topic>Neoplasms, Neuroepithelial - pathology</topic><topic>Pathology, Molecular - methods</topic><topic>Prognosis</topic><topic>Rosette Formation - methods</topic><topic>Tumors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singh, Vikram</creatorcontrib><creatorcontrib>Gupta, Kirti</creatorcontrib><creatorcontrib>Salunke, Pravin</creatorcontrib><creatorcontrib>Kumar, Sandeep</creatorcontrib><creatorcontrib>Radotra, Bishan Dass</creatorcontrib><creatorcontrib>Vasishta, Rakesh Kumar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical neuropathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singh, Vikram</au><au>Gupta, Kirti</au><au>Salunke, Pravin</au><au>Kumar, Sandeep</au><au>Radotra, Bishan Dass</au><au>Vasishta, Rakesh Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rosette-forming and papillary glioneuronal tumors - A clinicopathological and molecular analysis</atitle><jtitle>Clinical neuropathology</jtitle><addtitle>Clin Neuropathol</addtitle><date>2019-07</date><risdate>2019</risdate><volume>38</volume><issue>4</issue><spage>180</spage><epage>188</epage><pages>180-188</pages><issn>0722-5091</issn><abstract>Rosette-forming glioneuronal tumors (RGNT) and papillary glioneuronal tumors (PGNT) account for &lt; 1% of brain tumors. Genetic data regarding RGNT and PGNT is still evolving. We aimed to perform a detailed clinicopathological analysis on rosette-forming and papillary glioneuronal tumors and to evaluate these for common, known genetic mutations. Our cohort consisted of 6 cases of these rare glioneuronal tumors diagnosed over a period of 5 years. IDH1, ATRX, p53, and BRAF V600E mutations were evaluated on immunohistochemistry, and cases of RGNT were screened for the mutations in gene at hotspots exon 4, 9, and 20. Our findings confirm the presence of gene mutations in RGNT along with two novel mutations in gene, of which one is proposed to be of prognostic significance.
.</abstract><cop>Germany</cop><pub>Dustri - Verlag Dr. Karl Feistle GmbH &amp; Co. KG</pub><pmid>30900987</pmid><doi>10.5414/NP301164</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0722-5091
ispartof Clinical neuropathology, 2019-07, Vol.38 (4), p.180-188
issn 0722-5091
language eng
recordid cdi_proquest_miscellaneous_2196514474
source MEDLINE; Alma/SFX Local Collection
subjects Adult
Age
Brain cancer
Brain Neoplasms - diagnosis
Brain Neoplasms - pathology
Central Nervous System Neoplasms - diagnosis
Central Nervous System Neoplasms - pathology
Cerebral Ventricle Neoplasms - diagnosis
Cerebral Ventricle Neoplasms - pathology
Female
Histopathology
Humans
Immunohistochemistry - methods
Male
Medical education
Morphology
Mutation
Mutation - genetics
Neoplasms, Neuroepithelial - diagnosis
Neoplasms, Neuroepithelial - pathology
Pathology, Molecular - methods
Prognosis
Rosette Formation - methods
Tumors
Young Adult
title Rosette-forming and papillary glioneuronal tumors - A clinicopathological and molecular analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A52%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rosette-forming%20and%20papillary%20glioneuronal%20tumors%20-%20A%20clinicopathological%20and%20molecular%20analysis&rft.jtitle=Clinical%20neuropathology&rft.au=Singh,%20Vikram&rft.date=2019-07&rft.volume=38&rft.issue=4&rft.spage=180&rft.epage=188&rft.pages=180-188&rft.issn=0722-5091&rft_id=info:doi/10.5414/NP301164&rft_dat=%3Cproquest_cross%3E2196514474%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2370531829&rft_id=info:pmid/30900987&rfr_iscdi=true